Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1393 - 1400 of 12142 results

California Health Care Legislative Update: Fall 2023
November 7, 2023| Blog| Viewpoint

White House Issues Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence
November 7, 2023| Blog| Viewpoint

Retirement Pros Sound Off On DOL’s New Fiduciary Rule
November 7, 2023| News

US-Canada Critical Mineral, EV Battery, and Semiconductor Cross-Border Supply Chain Issues
November 6, 2023| Article| Viewpoint

HHS Proposes Appropriate Disincentives for Health Care Providers That Commit Information Blocking
November 6, 2023| Blog| Viewpoint

Energy & Sustainability Washington Update — November 2023
November 2, 2023| Blog| Viewpoint

Citizen Suits Seek To Expand CWA Permitting As WOTUS Narrows Scope
November 2, 2023| News

Biden Executive Order Calls for HHS to Establish Health Care-Specific Artificial Intelligence Programs and Policies
November 2, 2023| Blog| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts

Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|

Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
